Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol


Duygu H., Turk U., Ozdogan O., Akyuz S., Kirilmaz B. , Alioglu E., ...Daha Fazla

CARDIOVASCULAR THERAPEUTICS, cilt.26, ss.182-188, 2008 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 26 Konu: 3
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1111/j.1755-5922.2008.00050.x
  • Dergi Adı: CARDIOVASCULAR THERAPEUTICS
  • Sayfa Sayıları: ss.182-188

Özet

Introduction: Although beta-blockers are highly effective in the treatment of heart failure (HF), many patients with HF receiving a beta-blocker continue to become decompensated and re( hospitalization for worsening HF. Levosimendan and dobutaminc are used to manage decompensated HF, but their comparative effects on left ventricular (LV) function in patients prescribed beta-blockers are unknown.